Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8225853 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
SHORT is an effective bridging therapy for patients awaiting LT for HCC. It provides excellent in-field control with minimal side effects, helps to downsize or stabilize tumors prior to LT, and achieves good pathological response.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alan W. M.D., M.P.H., Sheema M.D., Zhenhong M.D., Ph.D., Randeep M.D., Michael T. M.D., Ph.D., Aram F. M.D.,